Neoantigens are novel proteins that form on cancer cells following the development of mutations in the tumor-cell DNA. These proteins are new to the immune system and are not part of the collection of self-proteins to which immune cells are tolerant or non-responsive. Therefore, neoantigens have the ability to trigger an impressive and very specific [...]Share ThisThe post Neoantigens Revive Vaccine Opportunities in Immuno-Oncology appeared first on Bioanalytical Lab & Top CRO for Large Molecule Bioanalysis.
MicroConstants is a California-based contract research organization that offers services such as bioanalysis and pharmacokinetics for the pharma and biotech industries.